← All trials
NCT00201279
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 1999
- Primary completion
- —
- Completion date
- Sep 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 342
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Government of TaiwanLead sponsor
- National Taiwan UniversityStudy chair
- National Taiwan UniversityCollaborator
- Changhua Christian HospitalCollaborator
- Taichung Veterans General HospitalCollaborator
- Sun Yat-Sen UniversityCollaborator
- Tzu Chi UniversityCollaborator
- Chang Gung UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- Chimei Medical CenterCollaborator
- China Medical UniversityCollaborator
- Mackay Medical CollegeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.